Eugene Shenderov
Johns Hopkins University
H-index: 13
North America-United States
Top articles of Eugene Shenderov
Development and demonstration of a user-friendly application to explore single-cell atlas for prostate cancer (PCa) and analyze newly generated single-cell and spatial PCa datasets
Cancer Research
2024/3/22
Eugene Shenderov
H-Index: 7
Utilizing whole-transcriptome digital spatial profiling for glioblastoma clinical biomarker discovery
Cancer Research
2024/3/22
Ezra Baraban
H-Index: 8
Eugene Shenderov
H-Index: 7
Investigating B7-H3 as a checkpoint and antibody drug conjugate target across prostate cancer variants-both androgen receptor dependent and independent
Cancer Research
2024/3/22
Nikita Mundhara
H-Index: 1
Eugene Shenderov
H-Index: 7
Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer
npj Genomic Medicine
2024/1/22
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Scientific reports
2024/1/17
Nirmish Singla
H-Index: 19
Eugene Shenderov
H-Index: 7
CLRM-09 MAPPING THE DISTRIBUTION AND CLINICAL ASSOCIATIONS OF BRAIN METASTASES IN RENAL CELL CARCINOMA
Neuro-Oncology Advances
2023/8
MLH1 Loss in Primary Prostate Cancer
JCO precision oncology
2023/5
Eugene Shenderov
H-Index: 7
Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
Nature medicine
2023/4
PD43-05 IMMUNOMODULATORY RESPONSE TO NEOADJUVANT NIVOLUMAB IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA: RESULTS FROM a PHASE I TRIAL
The Journal of Urology
2023/4
B7-H3 and Prostate Cancer: New Therapeutic Dance Partners
2023/3
Eugene Shenderov
H-Index: 7
757 A phase 1/1b dose escalation and cohort expansion study of MGC018 in combination with lorigerlimab in patients with advanced solid tumors (AST)
2022/11/1
Eugene Shenderov
H-Index: 7
Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer
Cancer
2022/6/15
Jianfeng Xu
H-Index: 3
Eugene Shenderov
H-Index: 7
Targeting B7-H3 in prostate cancer: phase 2 trial in localized prostate cancer using the anti-B7-H3 antibody enoblituzumab, with biomarker correlatives
J Clin Oncol
2022/6/1
Eugene Shenderov
H-Index: 7
Hao Wang
H-Index: 29
Abstract PO-100: Association of B7-H3 expression with racial ancestry, immune cell density and AR activation in prostate cancer
Cancer Epidemiology, Biomarkers & Prevention
2022/1/1
Jianfeng Xu
H-Index: 3
Eugene Shenderov
H-Index: 7
Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features
NPJ precision oncology
2021/5/14
Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial
The Prostate
2021/5
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide
Journal for immunotherapy of cancer
2021
Eugene Shenderov
H-Index: 7
627P Phase II neoadjuvant trial of the anti–B7-H3 antibody, enoblituzumab, in men with localized prostate cancer: Safety, efficacy and immune correlates
Annals of Oncology
2021/9/1
620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: preliminary results of phase I cohort expansion
Annals of Oncology
2021/9/1
Eugene Shenderov
H-Index: 7
Wen Xu
H-Index: 8
Deep Learning for distinguishing morphological features of acute promyelocytic leukemia
Blood
2020/11/5
John-William Sidhom
H-Index: 10
Eugene Shenderov
H-Index: 7
Co-Authors
